Kura Oncology, Inc. (KURA)

9.78 +0.17 (+1.77%) USD  |  NASDAQ  |  Oct 15, 10:53
More

Kura Oncology Total Long Term Debt (Quarterly) : 23.16M for June 30, 2026

Total Long Term Debt (Quarterly) Chart

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 23.16M
March 31, 2026 22.99M
December 31, 2025 19.18M
September 30, 2025 18.04M
June 30, 2025 17.78M
March 31, 2025 17.45M
December 31, 2024 14.71M
September 30, 2024 14.94M
June 30, 2024 15.27M
March 31, 2024 15.61M
December 31, 2023 15.69M
September 30, 2023 15.74M
June 30, 2023 10.70M
March 31, 2023 11.21M
December 31, 2022 11.71M
September 30, 2022 3.08M
June 30, 2022 3.602M
March 31, 2022 4.114M
December 31, 2021 4.612M
September 30, 2021 5.103M
June 30, 2021 4.755M
March 31, 2021 11.70M
December 31, 2020 12.89M
Date Value
September 30, 2020 13.52M
June 30, 2020 13.52M
March 31, 2020 9.30M
December 31, 2019 7.50M
September 30, 2019 7.50M
June 30, 2019 7.523M
March 31, 2019 7.614M
December 31, 2018 7.50M
September 30, 2018 6.266M
June 30, 2018 6.963M
March 31, 2018 7.155M
December 31, 2017 7.098M
September 30, 2017 7.042M
June 30, 2017 7.355M
March 31, 2017 7.339M
December 31, 2016 7.324M
September 30, 2016 7.308M
June 30, 2016 7.292M
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Inovio Pharmaceuticals, Inc. 5.103M
Fortress Biotech, Inc. 46.07M
Spero Therapeutics, Inc. 0.043M
Gossamer Bio, Inc. 39.10M
ACADIA Pharmaceuticals, Inc. 59.55M